It is unclear whether estrogen and its receptors affect sex-dependent tumor susceptibility and hepatic gene expression directly in the liver or indirectly, such as through the GH-regulated hypothalamic-pituitary-liver axis or through anti-inflammatory effects [17]. The gene discussed is GH1; the disease is neoplasm.